Case studies
Working with our customers to reduce time to market, deliver on quality, provide deep therapeutic expertise, and enhance R&D ROI.
Highlights
We focus our innovation on the factors that matter most — accelerating time to market, reducing costs and enhancing quality. Learn more about how we've helped clients meet and exceed their goals in this selected library of case studies.
Proactive patient retention strategy in a GLP-1 RA trial
Explore how ICON successfully supported a sponsor’s cardiovascular outcome trial for a GLP-1 receptor agonist with 9,900+ patients with type 2 diabetes and maintained a retention rate of 97% over 7 years.
A small biotech success story
A small US-based biotech company was in a race to be the first to market with their lead targeted oncology product.
FSP partnership - sustained efficiency and ongoing innovation
The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.
By taking a site and patient-centric approach, and leveraging advanced tools and real-time data insights, we maximise patient access, recruitment, and retention—ensuring that every trial is conducted with efficiency, agility, and a commitment to improving patient outcomes.
All case studies
Select amongst our broad range of solutions and experience.
Driving data excellence across a global R&D portfolio
A large global pharmaceutical sponsor engaged ICON to stabilise, modernise, and scale Clinical Data Science (CDS) delivery across more than 90 active studies.
A decade-long partnership driving eTMF Hub expansion
A top pharmaceutical company partnered with ICON to standardize TMF management and ensure global inspection readiness. ICON’s customized model enabled a decade-long FSP partnership, driving innovation and leading to eTMF Hub.
Blended FSP-FSO model powers global expansion for Chinese Biotech
In 2023, a leading China-based biotech firm partnered with ICON to launch a global programme for a key asset. Building on a six-year strategic alliance and success in China, the client expanded into the US and Europe, prioritizing efficiency and cost control. ICON deployed a blended model—FSP in China and the US, and full-service support in Europe — to align with regional needs and strategic goals.
Strategic expansion of Clinical Operations support and TMF hub
In July 2024, a global biopharma client partnered with ICON to expand functional support. Starting with Clinical Operations and TMF roles, the partnership grew to over 60 FTEs and now includes Clinical Quality, Systems Experts, and Late Phase, with further expansion underway.
From targeted engagement to global, multi-functional collaboration
In February 2023, a global biopharma company added ICON to its vendor ecosystem, initially focusing on Clinical Operations. Within a year, ICON grew to represent 20.5% of total FSP resourcing, outperforming expectations and becoming a key partner. ICON has since expanded into multiple services, offering flexible commercial models and scalable support across the client’s evolving needs.
Accelerating team growth to support client demand
This case study shows the effectiveness of this agile and forward-thinking approach to workforce scaling under time-
sensitive conditions.
sensitive conditions.
Custom FSP+ model drives sponsor success
A Top 10 biopharma company aimed to expand trials across CEE, including new markets. ICON delivered a custom model combining full operational ownership with local expertise and embedded governance to ensure consistency in a global, multi-vendor FSP setup.
Seamless transition to Functional Service Provider for medical writing
Outsourcing to an FSP often raises concerns about control, visibility, and quality. When a top-20 pharma company partnered with ICON for medical writing, ICON’s tailored approach ensured a smooth transition without sacrificing oversight or standards—building a strong, lasting partnership.
Securing the CRA talent pipeline in the US for a pharmaceutical company
A multinational pharmaceutical company, of ICON’s functional services provider clients, approached our team to resource CRAs in the US.
Delivering high quality at low cost
We created a more sustainable organisational design for our partner, within their Data Management and Biostatistics functions, resulting in a 56% cost saving.
FSP partnership - sustained efficiency and ongoing innovation
The implementation of an FSP model across our partner's project management function, led to 20% cost efficiences and a 30% reduction in client burden.
Vendor consolidation with a top 10 pharma company
Read more about how we consolidated over 340 site management resources, from 70 vendors, across 30 countries resulting in a 91% reduction in client burden.
Let's collaborate
Discover how ICON's expertise transforms clinical trials.